Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 287

Emailed: 0

PDF Downloaded: 832


Akhtar, Praveen, and Aafreen: Current concepts in management of amblyopia- A major review


Introduction

Amblyopia (means Lazy eye) is defined as uniocular or binocular reduction of best corrected visual acuity caused by form vision deprivation and /or abnormal binocular interaction.1 It is the main cause of preventable blindness in young with prevalence of approximately 1-5%.2 The common amblyogenic risk factors include preterm babies, small for gestational age,3, 4, 5, 6, 7 delay in achieving milestone, 7 history of amblyopia in first degree member, 8, 9 maternal smoking, drugs and alcohol use during pregnancy. Visual loss in amblyopia is reversible if detected early and treated in time.10 In amblyopia, there is decrease in best corrected visual acuity, contrast, vernier acuity and contour detection.

The causes of amblyopia include- Strabismus (most common), anisometropia, ametropia, sensory deprivation and organic causes.

Amblyopia is mainly categorized as follows:

  1. Strabismic amblyopia- Due to poor alignment of the visual axis, eyes do not receive equal stimulation. 11

  2. Anisometropic amblyopia- Occurs due to difference in refractive error of two eyes. In hypermetropia (> 1 dioptre) and in myopia (> 2.5 dioptres).

  3. Deprivation amblyopia- It occurs in condition in which light does not reach upto the retina like in ptosis, media opacities and nystagmus.

  4. Mixed amblyopia- It is considered mixed when two factors causing amblyopia is present simultaneously like in microtropia and monofixation syndrome. 11, 12

Bilateral amblyopia is usually defined as when best corrected visual acuity is less than 20/50 in children of age less than 4 years, less than 20/40 in children of age 4-5 years, or less than 20/30 in children of age more than 5 years. Unilateral amblyopia is defined as a difference in best corrected visual acuity of 2 or more lines between eyes. 13

  1. Mild amblyopia is classified as best corrected visual acuity of 6/9 to 6/12.

  2. Moderate amblyopia is best corrected visual acuity of 6/12 to 6/36.

  3. Severe amblyopia is best corrected visual acuity less than 6/36.

Recent trends in Amblyopia Treatment

The cornerstone of treatment is based on increasing stimulation of eye having less visual acuity by temporarily patching the good eye, either by using patch or atropine. It requires special effort by the child and family members. The treatment method should be tailored according to the age, degree of amblyopia and socioeconomic status of patient. The response to therapy depends upon factors such as age at which therapy was started, visual acuity at presentation, method of therapy, duration of therapy, compliance and cause of amblyopia. The critical period beyond which efficacy of amblyopia therapy reduces was considered to be seven years of age. 14

Optical correction

Refractive error correction by spectacles prescription is the basic and foremost step in management of amblyopia no matter what the intrinsic cause. A guideline is given by the American Academy of Ophthalmology in 2018 for refractive prescription. 15 By advising the best refractive correction , a sharp image is provided to fovea which leads to gain in visual acuity. The favourable outcome of optical correction on amblyopia has been confirmed by studies. Moseley et al conducted a study in amblyopic children and found that there is significant gain in visual acuity (VA) occurs after a time of 4-24 weeks alone in response to refractive error correction. 16 Stewart et al found that optical correction alone in new cases of amblyopia resulted in gain in visual acuity after 18 weeks of treatment. 17

The suggested time duration to achieve paramount response of optical correction is 18-22 weeks. 18 Hence, it is recommended that optical correction of refractive error in amblyopic patient should be the first and foremost line of management.

Occlusion therapy

If there is no gain in visual acuity occurs in amblyopic eye by using glasses alone, and there is a difference of 0.2 log MAR or more between each eye, patching should be started. Patching involves covering of better eye to stimulate the amblyopic eye using opaque adhesive patch which should be applied directly onto the eye under spectacles. There are different methods of patching by means of gauze piece, transpore tape, rubber patch, opaque patch under or on the glasses.

Paediatric Eye Disease Investigator Group (PEDIG) has done several multicentric studies to assess different patching methods for distinct degree of amblyopia (mild, moderate and severe) as Amblyopia Treatment Study (ATS). The effect of full time patching vs.6 hours of patching in 3-7 years of children (VA in amblyopic eye 20/100-20/400) was compared and result (VA improvement) was similar in both groups [ATS 1]. 19 The effect of 6 hours patching vs. 2 hours patching in 3-7 years of children (VA in amblyopic eye 20/40 to 20/80) was compared and showed that two hours of daily patching was as effective as six hours of patching per day[ ATS2a].20 In older children (13-17 years) trial of patching should always be given, even if they have not been treated earlier.21, 22, 23 During patching time, parents are instructed to involve child in near work or activities that requires coordination between hand and eye like sketching, playing video games, picture outlining or puzzle solving. 24

Atropine penalization

Atropine ointment 1% produces cycloplegia in the dominant eye. It is used as an auxiliary choice to patching, particularly in case of poor compliance. Atropine ointment 1% leads to loss of accommodation by paralyzing the ciliary muscle which defocuses the non- amblyopic eye.

Foley-Nolan et al conducted a study in which he found that atropine penalization for amblyopia due to improper alignment / difference in refractive error has been as good as patching. 25

PEDIG trials have compared the effect of patching for 6 hours per day vs. atropine drops 1% every morning in children aged 3-7 years with moderate amblyopia.26, 27, 28, 29 VA improvement occurs more in the patching group as compared to the atropine group after 6 months of therapy. 28 Repka MX et al conducted 2 prospective study in children with severe amblyopia. In trial 1--, 60 children of age 3-6 years were enrolled and in trial 2--, 40 children of age 7-12 years were enrolled. They found that weekend use of atropine (1%) also improve the visual acuity in children. 30

Also daily use of atropine when compared with weekend use of atropine showed equivocal results [ATS4].

Optical penalization

It refers to the blurry of sound eye by using translucent filters, overplus glasses, tape on glasses. It is mainly given in child who has been previously managed with atropine ointment 1%, but failed to gain normal visual acuity. It has been presumed that optical penalization and atropine might have synergistic effect as a combined therapy. 31, 32

Medical Therapy

Levodopa

Dopamine is a chemical which is present in retina and cortex and is involved in visual system plasticity in cortex. PEDIG investigators conducted a randomized trial for treatment of amblyopia in children aged 7-12 years. They prescribed daily levodopa-carbidopa in addition to 2 hours patching per day and found that there is no improvement occurs in best corrected visual acuity. Sofia et al reported that there is significant gain in visual acuity occurs at 1 year of follow-up; however, the dose of levodopa was thrice as compared to PEDIG study. 33

Citicoline

It is also known as cytidine diphosphatecholine. Citicoline have a neuroprotective effect by maintaining cell membrane integrity. 34 A RCT was conducted in children between age 4-13 years and was found that the gain in visual acuity with citicoline and patching was significantly higher as compared to patching alone after one year of treatment. 35

Need for Newer Treatment Modalities

Conventional treatment modalities have dominated in the field of strabismus for many years but due to many side effects of occlusion therapy and atropine, patient compliance is poor. Side effects of patching is occlusion amblyopia, cosmetic problem, psychological problems, suppression, difficulty in depth perception and ocular deviation due to fusion disruption. Atropine penalization also have side effects due to systemic absorption of drug, allergic reaction.

Newer Treatment for Amblyopia

Newer modalities for amblyopia management has been a topic of interest among clinicians and ophthalmologist.

Intermittent occlusion glasses liquid crystal eyeglasses has been introduced as an alternative modality for amblyopia treatment. It provides an electronic, controlled occlusion of the sound eye. 36, 37

The lenses used in glasses can be programmed to turn opaque, which work as a patch that flickers on and off in front of non-amblyopic eye. The flickering interval depends upon patient’s age, level of amblyopia and duration of treatment. There have been one study which compare the effect of liquid crystal eyeglasses and patching in which they found that in children of age 3-8 years with moderate unilateral amblyopia, 4 hours per day intermittent occlusion with LCG was as effective to 2 hours patching daily after 12 weeks of treatment. 38

Perceptual Learning

Perceptual learning is defined as any consistent change in the perception of a sensory task following repeated practice.39, 40 It involves administrating a single visual stimulus to each eye simultaneously. Visual task include vernier acuity, positional discrimination, contrast detection, letter identification in noise. 41

When it is given with patching for short time result is better as compared to patching for long time with passive stimulation for improving uniocular visual acuity.42

Binocular Therapy/ Dichoptic Therapy

In binocular therapy, images are projected to each eye separately and image having reduced contrast are given to sound eye to negate suppression and allow binocular vision. 43 A PEDIG trial was conducted in 385 children having amblyopia of age between 5 to 12 years to compare the efficacy of using iPad game for a hour daily versus patching for 2 hours daily on visual acuity. At 16 weeks of treatment, visual acuity improvement occurs slightly more in patching group. 44

Surgery for Refractive Errors

It is mainly performed in children having large difference in refractive errors and isometropia amblyopia.

Alio et al conducted a meta-analysis of visual outcome in anisometropic amblyopia after refractive surgery and found that a remarkable gain in best corrected visual acuity occurs in all patients and gain in acuity was better for patients undergoing surface ablation as compared to LASIK. 45

Conclusion

Amblyopia is a neurodevelopmental disorder of the visual system due to abnormal visual stimulus. Screening and treatment of amblyopia should begin as early as possible. Visual loss in amblyopia may be reversed with appropriate visual stimulation. Studies have shown that older amblyopic children also respond well to treatment. Thus, trial of amblyopia therapy should always be given to older children on diagnosis. The current treatment modalities include refractive correction, patching, followed by atropine penalization. However, the amblyopia treatment still remains burdensome due to poor compliance. Recently newer treatment modalities have developed in order to improve compliance and binocular function and more and more emphasis is being given on binocular visual stimulation. It is based on visual stimulation which leads to improvement in visual acuity. Binocular amblyopia treatments, which include playing videogame and watching movie might be fascinating to children and improve their compliance to treatment. 46

List of abbreviations

Best corrected visual acuity (BCVA), Visual acuity (VA), Randomized controlled trials (RCTs), Logarithm of the Minimum Angle of Resolution (log MAR), Pediatric Eye Disease Investigator Group (PEDIG), Liquid crystal glasses (LCG), Perceptual learning (PL).

Conflict of Interest

The authors declare that they have no conflict of interest.

Source of Funding

The authors received no funding for this work.

References

1 

G K Von Noorden E C Campos Binocular Vision and Ocular Motility: Theory and Management of StrabismusSt. Louis: Mosby1990

2 

K Attebo P Mitchell R Cumming W Smith N Jolly R Sparkes Prevalence and causes of amblyopia in an adult populationOphthalmology19981051154910.1016/s0161-6420(98)91862-0

3 

N Herbison S Cobb R Gregson I Ash R Eastgate J Purdy Interactive binocular treatment (I-BiT) for amblyopia: Results of a pilot study of 3D shutter glasses systemEye (Lond)201327910778310.1038/eye.2013.113

4 

J Li B Thompson D Deng LY Chan M Yu RF Hess Dichoptic training enables the adult amblyopic brain to learnCurr Biol2013238R308910.1016/j.cub.2013.01.059

5 

DP Spiegel J Li RF Hess WD Byblow D Deng M Yu Transcranial direct current stimulation enhances recovery of stereopsis in adults with amblyopiaNeurotherapeutics2013104831910.1007/s13311-013-0200-y

6 

LE Leguire GL Rogers PD Walson DL Bremer ML Mcgregor Occlusion and levodopa-carbidopa treatment for childhood amblyopiaJAAPOS1998252576410.1016/s1091-8531(98)90080-5

7 

K Mohan V Dhankar A Sharma Visual acuities after levodopa administration in amblyopiaJ Pediatr Ophthalmol Strabismus200138262710.3928/0191-3913-20010301-05

8 

MX Repka RT Kraker RW Beck CS Atkinson DA Bacal DL Bremer Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 yearsArch Ophthalmol201012891215710.1001/archophthalmol.2010.178

9 

S Dadeya P Vats K P Malik J Pediatr Ophthalmol StrabismusJ AAPOS2009462879010.3928/01913913-20090301-07

10 

G K Noorden Mechanisms of amblyopiaAdv Ophthalmol19773493115

11 

G Von Noorden E Campos Binocular Vision and Ocular Motility6th Edn.Mosby, IncSt. Louis, Missouri2002

12 

DR Weakley The association between nonstrabismic anisometropia, amblyopia, and subnormal binocularityOphthalmology200110811637110.1016/s0161-6420(00)00425-5

13 

DK Wallace MX Repka KA Lee M Melia SP Christiansen CL Morse Amblyopia preferred practice patternOphthalmology201812511054210.1016/j.ophtha.2017.10.008

14 

GK Von Noorden ML Crawford The sensitive periodTrans Ophthalmol Soc U K19799934426

15 

DK Wallace CL Morse M Melia Pediatric Eye Evaluations Preferred Practice Pattern: I. vision screening in the primary care and community setting; II. comprehensive ophthalmic examinationOphthalmology2018125118422710.1016/j.ophtha.2017.09.032

16 

MJ Moseley M Neufeld B Mccarry A Charnock R Mcnamara T Rice Remediation of refractive amblyopia by optical correction aloneOphthalmic Physiol Opt20022242969910.1046/j.1475-1313.2002.00034.x

17 

CE Stewart MJ Moseley AR Fielder DA Stephens MOTAS Cooperative Refractive adaptation in amblyopia: quantification of effect and implications for practiceBr J Ophthalmol200488121552610.1136/bjo.2004.044214

18 

SA Cotter NC Foster JM Holmes BM Melia DK Wallace MX Repka Optical treatment of strabismic and combined strabismic-anisometropic amblyopiaOphthalmology20121191150810.1016/j.ophtha.2011.06.043

19 

JM Holmes RT Kraker RW Beck EE Birch SA Cotter DF Everett A randomized trial of prescribed patching regimens for treatment of severe amblyopia in childrenOphthalmology20031101120758710.1016/j.ophtha.2003.08.001

20 

MX Repka RW Beck JM Holmes EE Birch DL Chandler SA Cotter A randomized trial of patching regimens for treatment of moderate amblyopia in childrenArch Ophthalmol200312156031110.1001/archopht.121.5.603

21 

K Mohan V Saroha A Sharma Successful occlusion therapy for amblyopia in 11- to 15-year-old childrenJ Pediatr Ophthalmol Strabismus2004412899510.3928/0191-3913-20040301-08

22 

MM Scheiman RW Hertle RW Beck AR Edwards E Birch SA Cotter Randomized trial of treatment of amblyopia in children aged 7 to 17 yearsArch Ophthalmol200512334374710.1001/archopht.123.4.437

23 

MH Brown PM Edelman Conventional occlusion in the older amblyopeAm Orthopt J197626346

24 

JM Holmes AR Edwards RW Beck RW Arnold DA Johnson DL Klimek A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopiaJ AAPOS2005921293610.1016/j.jaapos.2004.12.014

25 

A Foley-Nolan A Mccann M O'Keefe Atropine penalisation versus occlusion as the primary treatment for amblyopiaBr J Ophthalmol199781154710.1136/bjo.81.1.54

26 

MX Repka SA Cotter RW Beck RT Kraker EE Birch DF Everett A randomized trial of atropine regimens for treatment of moderate amblyopia in childrenOphthalmology200411111207685

27 

Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment studyAm J Ophthalmol20031364630910.1016/s0002-9394(03)00458-6

28 

MX Repka DK Wallace RW Beck Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in childrenArch Ophthalmol200512321495710.1001/archopht.123.2.149

29 

Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in childrenArch Ophthalmol200212032687810.1001/archopht.120.3.268

30 

MX Repka RT Kraker RW Beck E Birch SA Cotter JM Holmes Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trialsJ AAPOS20091332586310.1016/j.jaapos.2009.03.002

31 

DK Wallace EL Lazar MX Repka JM Holmes RT Kraker DL Hoover A randomized trial of adding a plano lens to atropine for amblyopiaJ AAPOS201519142810.1016/j.jaapos.2014.10.022

32 

Pediatric Eye Disease Investigator Group. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trialArch Ophthalmol20091271223010.1001/archophthalmol.2008.520

33 

IA Sofi SK Gupta A Bharti TG Tantry Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experienceInt J Health Sci201610224957

34 

JJ Secades G Frontera CDP-choline: pharmacological and clinical reviewMethods Find Exp Clin Pharmacol199517Suppl B154

35 

PV Pawar SS Mumbare MS Patil S Ramakrishnan Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: a randomized controlled trialIndian J Ophthalmol2014622124910.4103/0301-4738.128586

36 

O Benezra R Herzog E Cohen I Karshai D Benezra Liquid crystal glasses: feasibility and safety of a new modality for treating amblyopiaArch Ophthalmol200712545808110.1001/archopht.125.4.580

37 

A Spierer J Raz O Benezra R Herzog E Cohen I Karshai Treating amblyopia with liquid crystal glasses: a pilot studyInvest Ophthalmol Vis Sci20105173395810.1167/iovs.09-4568

38 

J Wang D E Neely J Galli J Schliesser A Graves TG Damarjian A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopiaJ AAPOS20162043263110.1016/j.jaapos.2016.05.014

39 

EJ Gibson Perceptual learningAnnu Rev Psychol196314295610.1146/annurev.ps.14.020163.000333

40 

U Polat Restoration of underdeveloped cortical functions: evidence from treatment of adult amblyopiaRestor Neurol Neurosci2008264-541324

41 

DM Levi RW Li Perceptual learning as a potential treatment for amblyopia: a mini-reviewVision Res20094921253549

42 

R W Li A Provost D M Levi Extended perceptual learning results in substantial recovery of positional acuity and visual acuity in juvenile amblyopiaInvest Ophthalmol Vis Sci20074811504651

43 

J Li B Thompson D Deng LY Chan M Yu RF Hess Dichoptic training enables the adult amblyopic brain to learnCurr Biol2013238R308910.1016/j.cub.2013.01.059

44 

JM Holmes VM Manh EL Lazar RW Beck EE Birch RT Kraker Effect of a binocular iPad game vs part-time patching in children aged 5 to 12 years with amblyopia: a randomized clinical trialJAMA Ophthalmol2016134121391140010.1001/jamaophthalmol.2016.4262

45 

JL Alió NV Wolter DP Piñero F Amparo ES Sari C Cankaya Pediatric refractive surgery and its role in the treatment of amblyopia: meta-analysis of the peer-reviewed literatureJ Refract Surg20112753647410.3928/1081597X-20100831-01

46 

V Tailor M Bossi J A Greenwood A Dahlmann-Noor Childhood amblyopia: current management and new trendsBr Med Bull20161191758610.1093/bmb/ldw030



jats-html.xsl

© 2022 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)